Italian agency threatens action over drug shortages due to parallel trade
This article was originally published in SRA
Executive Summary
The Italian regulatory agency AIFA has warned that it intends to clamp down on companies and wholesalers whose parallel exporting activity is found to be causing product shortages, after the pharmacist association Federfarma told the agency the lack of certain medicines on the Italian market was leading to "serious risks" to health1.